On this week’s Tech Nation, Moira speaks with Journalist and author Barry Werth about how the United States’ pharmaceutical industry came to be. His book, “The Age of Cures: How American Scientists Saved Your Life”, tells the stories of several individuals who managed to revolutionize drug research and development, which gave way to major breakthroughs in medicine. Then, Jeff Liter of Luminary Therapeutics shares how his team is working to make advanced cell therapy easier to access and more affordable.

On this week’s Tech Nation, it’s always nice to have the answers, right?Well… maybe that’s not true! Moira speaks with Columbia Professor Stuart Firestein about his new book, “It Could Be Otherwise: Science in the Age of Uncertainty,” and how we can embrace the not-always-knowing. Then, a potential biotech breakthrough for the treatment of gout - a disease that affects over 13 million people around the United States alone. Dr. James Mackay of Crystalys Therapeutics tells us about their new approach as they enter Phase III trials.

On this week’s Tech Nation, Moira speaks with Katie Prescott, author of “The Curious Case of Mike Lynch”, about a titan of the Tech world, who lost his life along with his daughter and others when his luxury yacht tragically sank off the coast of Sicily. What happened leading up to that day, and is there more to the story? Then, you may have heard of peptides, but what exactly are they? Dr. Karsten Eastman of Sethera Therapeutics explains how they work, and how Sethera plans to develop enhanced peptides to create new medicines, starting with triple-negative breast cancer.

On this week’s Tech Nation, Moira speaks with Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology, who are working on diseases of ageing before they even appear. Then, Tech Nation Health Chief Correspondent, Dr. Daniel Kraft, explains why mobility is the new vital sign. And Erica Dhawan, Author of Digital Body Language, tells us how to navigate the misinterpretations of digital communication.

On this week’s Tech Nation, Moira speaks with Stanford University Research Scholar Adrienne Mayor, to discuss what ancient myths tell us about the deep history of planet earth in her book "Mythopedia". Then in biotech, Dr. Ned Swanson, President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it’s twice as effective as the current treatment for diabetic foot ulcers.

On this week’s Tech Nation, Moira speaks with University of Chicago professor, Dr. Marc Berman, who tells us about "Nature and the Mind: The Science of How Nature Improves Cognitive, Physical, and Social Well-Being." Then in biotech, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, gives us the inside look on how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.

On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

On this week’s Tech Nation, Moira speaks with Dr. Paul Leonardi from UC Santa Barbara about “Digital Exhaustion: Simple Rules for Reclaiming Your Life”. Then, a promising new approach to flu shots! Dr. Jeff Stein from Cidara Therapeutics describes their efforts, now fast-tracked by the FDA.

On this week’s Tech Nation, Moira speaks with Dr. Frank Putnam, Psychiatrist and author of “Old Before Their Time” about his 35-year scientific investigation into the long-term biological effects of child abuse - and how trauma early in childhood can actually change the way a person ages. Then, Dr. Will Decker & Jay Hartenbach discuss how a discovery made over two decades ago set the stage for Diakonos Oncology’s new approach to treating glioblastoma… with a drug now entering phase two clinical trials.

On this week’s Tech Nation, Moira speaks with former New York Times journalist Katie Hafner about the Lost Women of Science initiative and what they’re doing to find and share the stories of women in science whose work has gone unrecognised. Then, CEO Lisa Deschamps tells us how Aviado Bio is working to correct the gene driving many cases of frontotemporal dementia.